16
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.64
Exchange
XHKG - Hong Kong Exchange
0.56 B
Last period CFO ,CNY
56%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Consun Pharmaceutical
Company Analysis
1681.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
1681.HK financial analysis by Eyestock methodology
Valuation
1681.HK valuation using historical relative method
Statements
1681.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
1681.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Consun Pharmaceutical`s CFO for the period ended 2023-12-31 is 0.56 B CNY
